BXP, Inc.

No Beneish M-Score, Piotroski F-Score, Altman Z-Score or Fog Index is on file for BXP in this data, so this synthesis does not assess any forensic score and gives no score values. The reading therefore rests on the reported figures and the filing text. The headline growth is modest: about 2% revenue growth in 2025 with net income of $276.8 million. Set against that, the 2025 impairment disclosures are large: $85.8 million at BXP and $145.1 million at an unconsolidated joint venture, which the company says could recur in future periods. Because net income is available only for 2025 in this data, a multi-year profit trend cannot be built from it, and operating income history stops at 2017, so readers may want to look at the full 10-K income statement and MD&A to see how the impairments were booked and whether they repeat. The capital structure disclosures are concrete. The 2.00% Exchangeable Senior Notes due 2030, issued in September 2025, come with capped call transactions whose counterparties are financial institutions. The filing says that exposure to those counterparties is unsecured and that BXP can provide no assurance of their financial stability. The first-quarter 2026 filing also shows employee incentive mechanics, including the February 2026 repurchase of 168,717 unearned 2023 MYLTIP units after the measurement period ended February 6, 2026. This is a routine governance item, but it is worth noting as a reflection of how compensation tied to total stockholder return vests. Readers may want to look at the market-by-market leasing exposure in the risk factors, since concentration in six metropolitan markets and in government, technology, and legal tenants is the structural feature that most shapes the company's sensitivity to the trends it describes.

Catalyst.According to the supplied annual figures, BXP's total revenues reached $3.48 billion for 2025, up from $3.41 billion in 2024, a rise of roughly 2%. Net income for 2025 was $276.8 million. The MD&A excerpt supplied covers only the Item 2 and Item 6 sections of the first-quarter 2026 10-Q and does not include the MD&A discussion of what drove operating results, so the specific growth drivers cannot be confirmed from this data. The one financing event visible in the excerpted risk factors is the September 2025 offering of 2.00% Exchangeable Senior Notes due 2030, paired with capped call transactions. The first-quarter 2026 filing states there were no material changes to the risk factors in the 2025 Form 10-K.

Hidden risk.The most material tension is between the revenue trend and impairments. For 2025, BXP recognized long-lived asset impairments of about $85.8 million (BPLP recognized about $82.9 million), and one unconsolidated joint venture recorded an other-than-temporary impairment of about $145.1 million. The filing warns that future impairments could materially affect results. Substantially all revenue comes from six markets: Boston, Los Angeles, New York, San Francisco, Seattle and Washington, DC. Specific submarkets depend on federal government contractors, technology and media tenants, and financial and legal firms. Remote work and workforce reductions tied to artificial intelligence are named as demand risks. No forensic scores are on file, so this section relies on the filing text and reported figures alone.